Fengmin Lu

10.3k citations

230 papers · 5.9k indexed · h-index 42

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Epidemiology 126
- Hepatitis B Virus Studies 100
- Liver Disease Diagnosis and Treatment 72
Hepatology 93
- Hepatitis C virus research 67
- Hepatitis Viruses Studies and Epidemiology 14
- Liver Disease and Transplantation 12

Co-authors: Xiangmei Chen (90 shared papers)Hui Zhuang (31 shared papers)Jun Nie (6 shared papers)J. Alan Diehl (3 shared papers)Dongzhi Yang (5 shared papers)Qiang Xu (3 shared papers)Yingshan Zhou (2 shared papers)Andrew B. Gladden (1 shared paper)
Journals: Journal of Medical Virology (9 papers)Emerging Microbes & Infections (9 papers)PLoS ONE (7 papers)Oncotarget (7 papers)Journal of Viral Hepatitis (7 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Fengmin Lu

219 papers receiving 5.8k citations

Peers

Countries citing papers authored by Fengmin Lu

Since Specialization

Citations

This map shows the geographic impact of Fengmin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Lu more than expected).

Fields of papers citing papers by Fengmin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengmin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Lu. The network helps show where Fengmin Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Fengmin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fengmin Lu Line = papers co-authored together Fengmin Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Electrospun Water-Soluble Carboxyethyl Chitosan/Poly(vinyl alcohol) Nanofibrous Membrane as Potential Wound Dressing for Skin Regeneration Biomacromolecules ·Yingshan Zhou, Dongzhi Yang, Xiangmei Chen, Qiang Xu, Fengmin Lu, Jun Nie	2007	378
2	Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) Journal of Clinical and Translational Hepatology ·Jinlin Hou, Guiqiang Wang, Fu‐Sheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei	2017	202
3	An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. PubMed ·Fengmin Lu, Andrew B. Gladden, J. Alan Diehl	2003	201
4	1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit Cancer Cell ·Wei Zhao, Li‐Min Wang, Haibo Han, Kemin Jin, Na Lin, Ting Guo, Yangde Chen, Heping Cheng, Fengmin Lu, Weigang Fang, Yu Wang, Baocai Xing, Zhiqian Zhang	2013	133
5	[Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. PubMed ·Guiwen Guan, Linbo Gao, Jianwen Wang, Xiajie Wen, Tianhao Mao, Siwen Peng, Ting Zhang, Xiangmei Chen, Fengmin Lu	2020	121
6	Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer Cancer Cell ·Olena Barbash, Petia Zamfirova, Douglas I. Lin, Xiangmei Chen, Yang Ke, Hiroshi Nakagawa, Fengmin Lu, Anil K. Rustgi, J. Alan Diehl	2008	118
7	Transmission of Hepatitis E Virus from Rabbits to Cynomolgus Macaques Emerging infectious diseases ·Peng Liu, Qiuning Bu, Ling Wang, Jian Han, Ren-Jie Du, Yaxin Lei, Yu-Qing Ouyang, Jie Li, Yonghong Zhu, Fengmin Lu, Hui Zhuang	2013	118
8	SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma Epigenetics ·Yan Jia, Yunsheng Yang, Shuang Liu, James G. Herman, Fengmin Lu, Mingzhou Guo	2010	117
9	Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex‐determining region Y box 6 in hepatocellular carcinoma Cancer ·Qing Xie, Xiangmei Chen, Fengmin Lu, Ting Zhang, Meili Hao, Yongfeng Wang, Jingmin Zhao, Malcolm A. McCrae, Hui Zhuang	2011	110
10	Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 Oncogene ·Sharon Benzeno, Fengmin Lu, Mian Guo, Olena Barbash, F Zhang, James G. Herman, Peter S. Klein, Anil K. Rustgi, J. Alan Diehl	2006	110
11	AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker International Journal of Cancer ·Jun Ma, Dixian Luo, Chenfei Huang, Yi Shen, Yiwen Bu, Stephen Markwell, John Gao, Jianghua Liu, Xuyu Zu, Zhe Cao, Zachary Gao, Fengmin Lu, Duan‐Fang Liao, Deliang Cao	2012	96
12	The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma Journal of Hepatology ·Xiaojun Li, Jiangbo Zhang, Ziwei Yang, Jingting Kang, Suzhen Jiang, Ting Zhang, Tingting Chen, Meng Li, Quanjun Lv, Xiangmei Chen, Malcolm A. McCrae, Hui Zhuang, Fengmin Lu	2013	90
13	Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein Small ·Ran Chen, Hongxin Huang, Hui Liu, Jingyuan Xi, Jing Ning, Wanjia Zeng, Congle Shen, Ting Zhang, Guangxin Yu, Qiang Xu, Xiangmei Chen, Jie Wang, Fengmin Lu	2019	82
14	Phylogenetic analysis of 626 hepatitis E virus (HEV) isolates from humans and animals in China (1986–2011) showing genotype diversity and zoonotic transmission Infection Genetics and Evolution ·Peng Liu, Ling‐Jun Li, Ling Wang, Qiuning Bu, Hongwei Fu, Jian Han, Yong-hong Zhu, Fengmin Lu, Hui Zhuang	2012	81
15	Epidemiology and prevention of hepatitis B virus infection in China Journal of Viral Hepatitis ·Fengmin Lu, Tingting Li, S. Liu, Hui Zhuang	2010	79
16	Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy Clinical Gastroenterology and Hepatology ·Yameng Sun, Xiaoning Wu, Jialing Zhou, Tongtong Meng, Bingqiong Wang, Shuyan Chen, Hui Liu, Tailing Wang, Xinyan Zhao, Shanshan Wu, Yuanyuan Kong, Xiaojuan Ou, Aileen Wee, Neil D. Theise, Chao Qiu, Wenhong Zhang, Fengmin Lu, Jidong Jia, Hong You	2020	72
17	In Situ Mineralization of Hydroxyapatite on Electrospun Chitosan‐Based Nanofibrous Scaffolds Macromolecular Bioscience ·Dongzhi Yang, Yu Jin, Yingshan Zhou, Guiping Ma, Xiangmei Chen, Fengmin Lu, Jun Nie	2008	72
18	Synthesis and characterization of chitosan-based hydrogels International Journal of Biological Macromolecules ·Qianzhu Li, Dongzhi Yang, Guiping Ma, Qiang Xu, Xiangmei Chen, Fengmin Lu, Jun Nie	2008	69
19	T-type Ca2+ channel expression in human esophageal carcinomas: A functional role in proliferation Cell Calcium ·Fengmin Lu, Hairu Chen, Chun Zhou, Shuang Liu, Mingzhou Guo, Pingping Chen, Hui Zhuang, Dong Xie, Songwei Wu	2007	67
20	Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals Journal of Clinical Virology ·Hongxin Huang, Jie Wang, Weijie Li, Ran Chen, Xiangmei Chen, Fengmin Zhang, Dongping Xu, Fengmin Lu	2018	66

About Fengmin Lu

Fengmin Lu is a scholar working on Epidemiology, Hepatology, Molecular Biology, Oncology and Immunology, having authored 230 papers that have together received 5.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (100 papers), Liver Disease Diagnosis and Treatment (72 papers), Hepatitis C virus research (67 papers), Hepatitis Viruses Studies and Epidemiology (14 papers), Epigenetics and DNA Methylation (13 papers), Liver Disease and Transplantation (12 papers), RNA modifications and cancer (10 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Hepatology (1.6k citations), Epidemiology (1.9k citations), Cancer Research (801 citations), Biomaterials (490 citations) and Oncology (907 citations). Fengmin Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiangmei Chen, Hui Zhuang, Jun Nie, J. Alan Diehl, Dongzhi Yang, Qiang Xu, Yingshan Zhou, Andrew B. Gladden, Jie Wang and Mingjie Yao. Their work appears in journals such as Journal of Medical Virology, Emerging Microbes & Infections, PLoS ONE, Oncotarget and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact